vs
Side-by-side financial comparison of ECARX Holdings Inc. (ECX) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $323.3M, roughly 1.9× ECARX Holdings Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -21.4%, a 24.7% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 6.5%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-86.5M).
ECARX Holdings Inc. is a global mobility technology provider specializing in integrated smart vehicle solutions, including in-vehicle infotainment systems, advanced driver assistance technologies, and connected car cloud services. It primarily partners with automotive manufacturers across the world, with a strong operational presence in the Chinese and European markets.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ECX vs HIMS — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $323.3M | $617.8M |
| Net Profit | $-69.1M | $20.6M |
| Gross Margin | 15.5% | 71.9% |
| Operating Margin | -20.2% | 1.5% |
| Net Margin | -21.4% | 3.3% |
| Revenue YoY | 6.5% | 28.4% |
| Net Profit YoY | 12.8% | -20.8% |
| EPS (diluted) | $-0.20 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $617.8M | ||
| Q3 25 | — | $599.0M | ||
| Q2 25 | $323.3M | $544.8M | ||
| Q1 25 | — | $586.0M | ||
| Q4 24 | — | $481.1M | ||
| Q3 24 | — | $401.6M | ||
| Q2 24 | $303.5M | $315.6M | ||
| Q1 24 | — | $278.2M |
| Q4 25 | — | $20.6M | ||
| Q3 25 | — | $15.8M | ||
| Q2 25 | $-69.1M | $42.5M | ||
| Q1 25 | — | $49.5M | ||
| Q4 24 | — | $26.0M | ||
| Q3 24 | — | $75.6M | ||
| Q2 24 | $-79.2M | $13.3M | ||
| Q1 24 | — | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | 15.5% | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | 22.6% | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | -20.2% | 4.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | -22.2% | 3.5% | ||
| Q1 24 | — | 3.6% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | -21.4% | 7.8% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | -26.1% | 4.2% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | $-0.20 | $0.17 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.32 | ||
| Q2 24 | $-0.23 | $0.06 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.2M | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-293.7M | $540.9M |
| Total Assets | $494.9M | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | $86.2M | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | $108.4M | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | — | $540.9M | ||
| Q3 25 | — | $581.0M | ||
| Q2 25 | $-293.7M | $562.7M | ||
| Q1 25 | — | $549.3M | ||
| Q4 24 | — | $476.7M | ||
| Q3 24 | — | $440.1M | ||
| Q2 24 | $-198.5M | $362.0M | ||
| Q1 24 | — | $344.5M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $494.9M | $1.9B | ||
| Q1 25 | — | $891.7M | ||
| Q4 24 | — | $707.5M | ||
| Q3 24 | — | $602.3M | ||
| Q2 24 | $555.0M | $480.5M | ||
| Q1 24 | — | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-82.0M | $61.3M |
| Free Cash FlowOCF − Capex | $-86.5M | $-2.5M |
| FCF MarginFCF / Revenue | -26.7% | -0.4% |
| Capex IntensityCapex / Revenue | 1.4% | 10.3% |
| Cash ConversionOCF / Net Profit | — | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | — | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $61.3M | ||
| Q3 25 | — | $148.7M | ||
| Q2 25 | $-82.0M | $-19.1M | ||
| Q1 25 | — | $109.1M | ||
| Q4 24 | — | $86.4M | ||
| Q3 24 | — | $85.3M | ||
| Q2 24 | $-57.1M | $53.6M | ||
| Q1 24 | — | $25.8M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $79.3M | ||
| Q2 25 | $-86.5M | $-69.5M | ||
| Q1 25 | — | $50.1M | ||
| Q4 24 | — | $59.5M | ||
| Q3 24 | — | $79.4M | ||
| Q2 24 | $-64.9M | $47.6M | ||
| Q1 24 | — | $11.8M |
| Q4 25 | — | -0.4% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | -26.7% | -12.8% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 19.8% | ||
| Q2 24 | -21.4% | 15.1% | ||
| Q1 24 | — | 4.3% |
| Q4 25 | — | 10.3% | ||
| Q3 25 | — | 11.6% | ||
| Q2 25 | 1.4% | 9.3% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | 2.6% | 1.9% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | — | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 4.03× | ||
| Q1 24 | — | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
